Curry-jones Syndrome
Description
Curry-Jones syndrome is a form of syndromic craniosynostosis characterized by unilateral coronal craniosynostosis or multiple suture synostosis associated with complete or partial agenesis of the corpus callosum, preaxial polysyndactyly and syndactyly of hands and/or feet, along with anomalies of the skin (characteristic pearly white areas that become scarred and atrophic, abnormal hair growth around the eyes and/or cheeks, and on the limbs), eyes (iris colobomas, microphthalmia,) and intestine (congenital short gut, malrotation, dysmotility, chronic constipation, bleeding and myofibromas). Developmental delay and variable degrees of intellectual disability may also be observed. Multiple intra-abdominal smooth muscle hamartomas, trichoblastoma of the skin, occipital meningoceles and development of desmoplastic medulloblastoma have been reported.
Clinical Features
Top most frequent phenotypes and symptoms related to Curry-jones Syndrome
- Intellectual disability
- Global developmental delay
- Microcephaly
- Hypertelorism
- Nystagmus
- Cataract
- Ptosis
- Ventriculomegaly
- Syndactyly
- Microphthalmia
And another 38 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Curry-jones Syndrome Is also known as corpus callosum agenesis-polysyndactyly syndrome, craniofacial malformations, asymmetric, with polysyndactyly and abnormal skin and gut development.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Curry-jones Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By CGC Genetics (Portugal).
SMO
Specificity
100 %
Genes
100 % |
![]() By Centogene AG - the Rare Disease Company (Germany).
BCL6, ROS1, BRAF, BRCA1, BRCA2, SMARCB1, SMO, SRC, STK11, HNF1A, TP53, TSC1, TSC2, VHL, EML4, BRD4, CCND1, CCNE1, FBXW7, CD74 , (...)
View the complete list with 68 more genes
Specificity
2 %
Genes
100 % |
![]() By Centogene AG - the Rare Disease Company (Germany).
ROS1, BRAF, SMARCA4, SMARCB1, ARID1A, SMO, STK11, TP53, TSC1, KDM6A, VHL, KMT2C, CDH1, CDK4, CDKN2A, ASXL1, CTNNB1, DDR2, EGFR, ERBB2 , (...)
View the complete list with 41 more genes
Specificity
2 %
Genes
100 % |
![]() By Fulgent Genetics Fulgent Genetics (United States).
SMO
Specificity
100 %
Genes
100 % |
![]() By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center (United States).
BLM, BRAF, BRCA1, BRCA2, SMARCB1, KDM5C, SMO, ABI1, SSX1, SSX2, SSX4, SS18, STAG2, STAT5B, TAF15, TCF12, TERT, TFE3, TFEB, TP53 , (...)
View the complete list with 69 more genes
Specificity
2 %
Genes
100 % |
![]() By Cancer Genetics, Inc. Cancer Genetics, Inc. (United States).
ROS1, BRAF, SMO, CDK4, CTNNB1, DDR2, EGFR, ERBB2, ERBB3, ERBB4, FGFR2, FGFR3, AKT1, MTOR, ALK, GNA11, GNAQ, HRAS, IDH1, IDH2 , (...)
View the complete list with 14 more genes
Specificity
3 %
Genes
100 % |
![]() By Cancer Genetics, Inc. Cancer Genetics, Inc. (United States).
RHEB, ROS1, BRAF, ARID1A, KDM5C, SMO, TP53, TSC1, TSC2, VHL, SETD2, PBRM1, EGFR, EPHB4, ERBB2, FGFR1, FLT3, AKT1, AKT2, MTOR , (...)
View the complete list with 12 more genes
Specificity
4 %
Genes
100 % |
![]() By Genomics and Pathology Services Washington University in St. Louis (United States).
SMO, TSC1, TSC2, AKT1, AKT2, AKT3, MTOR, GNA11, GNAQ, IDH1, IDH2, PIK3CA, PIK3R2, PTEN, RASA1
Specificity
7 %
Genes
100 % |
You can get up to 18 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET MESH Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2 HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5 MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3